For instance, congenital myasthenic syndrome patients living in France and originating from Tunisia, Algeria, Morocco, and Libya share the same haplotype associated with the point founder mutation (c.1293insG) in CHRNE which has been also found in patients from the Maghreb (Richard et al., 2008). Here, CHRNE is linked to congenital myasthenic syndrome.